708 filings
Page 7 of 36
EFFECT
fivz6l23
20 Apr 21
Notice of effectiveness
12:15am
424B3
0r8fho6tva8l
20 Apr 21
Prospectus supplement
12:00am
UPLOAD
dpjrb jwx3dvuk
14 Apr 21
Letter from SEC
12:00am
CORRESP
hxcl87rprr2aeiiexktn
14 Apr 21
Correspondence with SEC
12:00am
EFFECT
mbz6vcq ee
6 Apr 21
Notice of effectiveness
12:15am
424B3
086uqun3z4p25w
6 Apr 21
Prospectus supplement
12:00am
8-K
k3omsp3yx2o3c 46
5 Apr 21
Sorrento eNTERS INTO MERGER agreement tO acquire late-stage oncology company acea therapeutics
9:11am
CORRESP
h37lik
2 Apr 21
Correspondence with SEC
12:00am
CORRESP
ztzli8er2l
19 Mar 21
Correspondence with SEC
12:00am
UPLOAD
gfx 489s9i4
16 Mar 21
Letter from SEC
12:00am
8-K
flwi3w0uu r8kq
10 Mar 21
Other Events
1:36pm
8-K
c2plmjmipi8reer5
9 Mar 21
Entry into a Material Definitive Agreement
9:01am
8-K
ag959o 5mh586n
1 Mar 21
Entry into a Material Definitive Agreement
12:00am
8-K
9zycp
27 Jan 21
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
12:00am